Brief: Biosynex Q1 Unaudited Revenue Up At 75.0 Million Euros
April 15 (Reuters) - Biosynex SA ALBIO.PA :
* Q1 UNAUDITED REVENUE EUR 75.0 MILLION VERSUS EUR 13.4
MILLION
YEAR AGO
* ANTICIPATES THE CONTINUATION OF A VERY SIGNIFICANT
INCREASE IN
ITS TURNOVER IN Q2
* PLANS TO DELIVER 10 MILLION TESTS IN APRIL
Source text for Eikon: ID:nNDL8FqJgz
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals